WUXITECAN-2 Trademark

custom manufacture of antineoplastic pharmaceuticals containing a topoisomerase I inhibitor payload pharmaceuticals; Custom manufacturing of antineoplastic pharmaceuticals containing a topoisomerase I inhibitor payload pharmaceuticals; Manufacturing services for others in the field of antineoplastic pharmaceuticals containing a topoisomerase I inhibitor payload antibody drug conjugates and intermediates thereof; Custom manufacture of antineoplastic pharmaceuticals containing a topoisomerase I inhibitor payload pharmaceutical preparations, biomedical preparations, drug conjugates, anti-body drug conjugates, chemical reagents; Biomanufacturing for others of antineoplastic pharmaceuticals containing a topoisomerase I inhibitor payload pharmaceuticals using biological organisms in the manufacturing process

Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Research and development services of new pharmaceutical products; Research and development of antibody-drug conjugates; Research and development of conjugated antibodies; Product development consulting in the field of pharmaceuticals, anti-bodies, conjugated antibodies, chemical reagents; Product development for others; Biomedical research services; Scientific research in the nature of conducting clinical trials for others in the field of new pharmaceutical development

Active chemical ingredients for use in the manufacture of antineoplastic pharmaceuticals containing a topoisomerase I inhibitor payload pharmaceuticals; Chemical reagents, other than for medical or veterinary purpose; Biochemical catalysts; Biological preparations for use in the manufacture of antineoplastic pharmaceuticals containing a topoisomerase I inhibitor payload pharmaceuticals; Chemical preparations for scientific purposes, other than for medical or veterinary use; Heterocyclic compounds; Chemical preparations for use in the manufacture of antineoplastic pharmaceuticals containing a topoisomerase I inhibitor payload pharmaceuticals; Antibody reagents used for the detection of antigens in cells and tissue, other than for medical or veterinary purposes

antineoplastic pharmaceuticals containing a topoisomerase I inhibitor payload pharmaceutical preparations for inhibiting tumors; antineoplastic pharmaceuticals containing a topoisomerase I inhibitor payload pharmaceutical products for the prevention and treatment of cancer; Biological preparations for the treatment of cancer; Biological preparations for use in cell cultures for medical purposes; Chemical reagents for medical or veterinary purposes; Chemical reagents for medical purposes; Antibodies for medical purposes; Biologics in the nature of cells for the treatment of cancer